1.30 +0.04 (3.20%)
AMRN
Stock Details
Last Trade:1.30 Change:+0.04 (3.20%) Prev Close:1.26 Open: 1.25 Days Range:1.08 – 1.38 52 Week Range: 0.46 - 2.25 Volume:17601 P/E: N/AEPS:0.00
View AllRecent Alerts 07/04/09
Recent Alert on 06/10/09 at 9:36am
Morning Movers 6/10: JAZZ, CDIC, GRH, SHFL, AMRN Higher; SATC, MRNA, EFUT, NCS, SINA Lower
Morning Movers 6/10: JAZZ, CDIC, GRH, SHFL, AMRN Higher; SATC, MRNA, EFUT, NCS, SINA Lower
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) 71.6% HIGHER; announced after the close that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented this week during the... Read More
Recent Alert on 05/26/09 at 8:20am
Amarin (AMRN) Signs Term Sheet for Private $2.6M Bridge Financing
Amarin (AMRN) Signs Term Sheet for Private $2.6M Bridge Financing
Recent Alert on 05/06/09 at 9:36am
Amarin Corporation (AMRN) Reaches Agreement WIth FDA For Phase 3 Trial of AMR101
Amarin Corporation (AMRN) Reaches Agreement WIth FDA For Phase 3 Trial of AMR101
Recent Alert on 05/06/09 at 9:36am
Amarin Corporation (AMRN) Reaches Agreement WIth FDA For Phase 3 Trial of AMR101
Amarin Corporation (AMRN) Reaches Agreement WIth FDA For Phase 3 Trial of AMR101
View AllRecent Press Releases
Press Release on 07/01/09 at 9:10am
Amarin Reports Preliminary Unaudited Financial Results for the Six and Twelve Months Ended December 31, 2008
Amarin Reports Preliminary Unaudited Financial Results for the Six and Twelve Months Ended December 31, 2008
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 05/08/09 at 3:31am
FDA, Clinical Trial Calendar Updates: WYE, SVNT, AMRN, ISIS, SLXP, SOMX
FDA, Clinical Trial Calendar Updates: WYE, SVNT, AMRN, ISIS, SLXP, SOMX